On February 20, 2024, the IR-Med (OTC:IRME) announced highly favorable proof of efficacy data for PressureSafe, its decision support device which uses infra-red spectroscopy combined with an AI-based ...
We are initiating coverage of IR-Med, Inc. (OTC:IRME), a development stage medical device company that is creating a technology platform for non-invasive devices to be used as a decision support ...
IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications. The company’s development products pipeline consists of PressureSafe, a ...
Access detailed historical stock prices, including daily closing prices, for IRME. Analyze past performance trends, track price movements, and explore historical data to inform your investment ...
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
IR-Med's Potential for Profitable Growth in Coming Years Supports Price Target of $3.00 ...
Al cierre: 14 de noviembre, 16:00:00 GMT-5 Rentabilidad total acumulada hasta el 17/11/2025, que puede incluir dividendos u otras distribuciones. El valor de referencia es S&P 500 (^GSPC) . Select to ...
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results